SCHEMBL23738

SCHEMBL23738

CC(C)CCC[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL223672 0.90
SCHEMBL5507416 0.88 LMNA (0.68)
SCHEMBL5506093 0.88 LMNA (0.68)
SCHEMBL3090843 0.87 LMNA (0.50)
SCHEMBL3093760 0.87 LMNA (0.50)
SCHEMBL3097278 0.87 LMNA (0.50)
SCHEMBL3093387 0.87 LMNA (0.50)
SCHEMBL4644602 0.87 LMNA (0.50)
SCHEMBL4641507 0.87 LMNA (0.50)
SCHEMBL4646666 0.87 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12788 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151017-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE OSTEOARTHRITIS 주식회사 글라세움 2024-07-18 WO claimed
WO-2024140062-A1 THIOXANTHENIUM SALT PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 常州强力电子新材料股份有限公司 2024-07-04 WO claimed
WO-2024140063-A1 THIOXANTHENE SULFONIUM SALT PHOTOINITIATOR AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 常州强力电子新材料股份有限公司 2024-07-04 WO claimed
CN-118271281-A Thioxanthene sulfonium salt photoinitiator and preparation method and application thereof 常州强力电子新材料股份有限公司 2024-07-02 CN claimed
CN-118271280-A Thioxanthene sulfonium salt photoinitiator and preparation method and application thereof 常州强力电子新材料股份有限公司 2024-07-02 CN claimed
WO-2024120457-A1 PYRROLO[3,2-D]PYRIMIDIN-4-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 深圳信立泰药业股份有限公司 2024-06-13 WO claimed
US-20240166627-A1 Terpyridinedione compound or salt thereof, and preparation method and application thereof SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2024-05-23 US claimed
US-11987587-B2 Chiral bisamino-ether compounds, and method of preparation and use thereof UNIV JINAN (CN) 2024-05-21 US claimed
CN-117466803-A Compounds, salts thereof and methods for treating diseases 阿卡蒂亚药品公司 2024-01-30 CN claimed
CN-117326956-A Tetraphenyl ethylene derivative and organic electroluminescent device comprising same 广东省大湾区华南理工大学聚集诱导发光高等研究院 2024-01-02 CN claimed
US-6399628-B1 ALZHEIMER'S DISEASE ATHENA NEUROSCIENCES, INC. 2002-06-04 US claimed
JP-2001508408-A 2001-06-26 JP claimed
EP-1018506-A1 Substituted alkyltetramine derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2000-07-12 EP claimed
US-5965614-A A PEPTIDE BLOCKING AGENT FOR TREATING ALZHEIMER'S DISEASE ATHENA NEUROSCIENCES, INC. 1999-10-12 US claimed
EP-0944580-A2 N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS Elan Pharmaceuticals, Inc. (US) 1999-09-29 EP claimed
EP-0740669-B1 AZATRIOXASPIROALKENES AS PARASITICIDES BAYER AG (DE) 1999-04-28 EP claimed
WO-1998022441-A2 N-(ARYL/HETEROARYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE AND/OR ITS SYNTHESIS ELAN PHARMACEUTICALS, INC. (US) 1998-05-28 WO claimed
US-5294737-A Hydrolysis, cyclization, condensation THE RESEARCH FOUNDATION STATE UNIVERSITY OF NEW YORK (US) 1994-03-15 US claimed
EP-0520336-A2 Aldehyde derivatives and their use as calpain inhibitors FUJIREBIO Inc. (JP) 1992-12-30 EP claimed
US-5045108-A Herbicidal and plant growth-regulating N-aryl-pyrrol-L-one and isoindol-2-one compounds BAYER AKTIENGESELLSCHAFT (DE) 1991-09-03 US claimed